We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
+$369M
Cap. Flow
+$44.9M
Cap. Flow %
1.33%
Top 10 Hldgs %
35.85%
Holding
3,551
New
186
Increased
1,137
Reduced
1,414
Closed
232
Avg Time Held Equity + Options
4 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
2.7 years
Avg Time Held Equity only
4 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
2.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.92%
2 Technology 14.72%
3 Healthcare 9.12%
4 Financials 6.99%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ANIP icon
3301
ANI Pharmaceuticals
ANIP
$1.66B
– –
-56
Closed -$3.25K –
AOSL icon
3302
Alpha and Omega Semiconductor
AOSL
$697M
– –
-4
Closed -$119 –
APOG icon
3303
Apogee Enterprises
APOG
$854M
– –
-46
Closed -$2.17K –
APPS icon
3304
Digital Turbine
APPS
$1.26B
– –
-51
Closed -$309 –
ARDX icon
3305
Ardelyx
ARDX
$849M
– –
-1,000
Closed -$4.08K –
ARKW icon
3306
ARK Next Generation Technology ETF
ARKW
$2.24B
– –
-117
Closed -$6.34K –
ARTNA icon
3307
Artesian Resources
ARTNA
$343M
– –
-227
Closed -$9.53K –
OPTU icon
3308
Optimum Communications Inc
OPTU
$364M
– –
-101
Closed -$330 –
AVO icon
3309
Mission Produce
AVO
$1.06B
– –
-29
Closed -$281 –
AVTX icon
3310
Avalo Therapeutics
AVTX
$655M
– –
0
– –
2020 Q1
15 quarters
AWAY icon
3311
Amplify Travel Tech ETF
AWAY
$23.1M
– –
-5,914
Closed -$99.6K –
AXGN icon
3312
Axogen
AXGN
$2.08B
– –
-100
Closed -$500 –
AXS icon
3313
AXIS Capital
AXS
$7.15B
– –
-5
Closed -$282 –
BBIO icon
3314
BridgeBio Pharma
BBIO
$13.2B
– –
-28
Closed -$738 –
BBLU icon
3315
EA Bridgeway Blue Chip ETF
BBLU
$484M
– –
-62
Closed -$594 –
BCRX icon
3316
BioCryst Pharmaceuticals
BCRX
$2.04B
– –
-40
Closed -$283 –
BFH icon
3317
Bread Financial
BFH
$3.9B
– –
-5
Closed -$171 –
BFS icon
3318
Saul Centers
BFS
$720M
– –
-5
Closed -$176 –
BFST icon
3319
Business First Bancshares
BFST
$1.01B
– –
-507
Closed -$9.51K –
BIZD icon
3320
VanEck BDC Income ETF
BIZD
$1.46B
– –
-7,000
Closed -$112K –
GENZ icon
3321
VanEck Digital Native Economy ETF
GENZ
$16.4M
– –
-800
Closed -$31.8K –
BLFS icon
3322
DELISTED
BioLife Solutions
BLFS
– –
-1,096
Closed -$15.1K –
BLMN icon
3323
Bloomin' Brands
BLMN
$853M
– –
-29
Closed -$713 –
BLUE icon
3324
DELISTED
bluebird bio
BLUE
– –
0
– -$27
2023 Q4
0 quarters
BSVO icon
3325
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.41B
– –
-4,513
Closed -$82.5K –

Similar funds

Parallel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Parallel Advisors held 3,551 positions worth $3.37B, up 12% from $3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q4 2023 filing shows 186 new, 1,137 increased, 1,414 reduced and 232 closed positions. Its largest new stake was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M. The largest sale was Schwab US Dividend Equity ETF, an estimated $69.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q4 2023 buy was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $174M increase.
  • Parallel Advisors's biggest Q4 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $69.6M.
  • Parallel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $591K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.37B portfolio in Q4 2023.
  • Parallel Advisors opened 186 new positions and closed 232 in Q4 2023.
  • Parallel Advisors's portfolio value rose 12% quarter-over-quarter to $3.37B.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.